首页> 外国专利> Gene therapy vector and method for quantifying target protein in mammals or cultured cells to which the gene therapy vector is administered

Gene therapy vector and method for quantifying target protein in mammals or cultured cells to which the gene therapy vector is administered

机译:基因治疗载体和定量给予该基因治疗载体的哺乳动物或培养细胞中的靶蛋白的方法

摘要

Disclosed is a gene therapy vector that can monitor the blood concentration of a target protein at the time of gene therapy with higher sensitivity, and that the labeled peptide has no physiological effect and is not immunogenic in many animals. Yes. A gene therapy vector has a structure in which a nucleic acid encoding a fusion protein of a C-terminal 19-29 amino acid peptide region of glucagon and a target protein region to be produced in the body is incorporated into an expression vector for mammalian cells.
机译:公开了一种基因治疗载体,其可以在基因治疗时以更高的敏感性监测靶蛋白的血药浓度,并且标记的肽没有生理作用并且在许多动物中都不具有免疫原性。是。基因治疗载体具有这样的结构,其中将编码胰高血糖素的C末端19-29氨基酸肽区和体内产生的靶蛋白区的融合蛋白的核酸掺入哺乳动物细胞的表达载体中。 。

著录项

  • 公开/公告号JPWO2004062693A1

    专利类型

  • 公开/公告日2006-05-18

    原文格式PDF

  • 申请/专利权人 株式会社新潟ティーエルオー;

    申请/专利号JP20040566302

  • 发明设计人 塙 晴雄;

    申请日2003-12-26

  • 分类号C12N15/09;A61K48;G01N33/53;C07K14/605;A61K38;A61K38/21;A61K38/22;

  • 国家 JP

  • 入库时间 2022-08-21 21:49:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号